STYE EYE RELIEF SERUM
NDC 84896-005, vitamin E, lysine, liquid, from Guangzhou Mizi Biotechnology Co., LTD..
- Product NDC
- 84896-005
- Status
- Listed
- Labeler
- Guangzhou Mizi Biotechnology Co., LTD.
- Dosage form
- LIQUID
- Route
- OPHTHALMIC
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- 505G(a)(3)
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/84896-005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LYSINE.01 g/mL
- ASPARTIC ACID.02 g/mL
- OLIGOPEPTIDE-10.01 g/mL
- SODIUM HYALURONATE.001 g/mL
- .ALPHA.-TOCOPHEROL.02 g/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 84896-005-01 | 84896000501 | 30 mL in 1 BOTTLE (84896-005-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 84896-005 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/84896-005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 84896-005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.